Montvale, NJ, United States of America

Matthew James Kaser

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Montvale, NJ (US) (2012)
  • Parsippany, NJ (US) (2016 - 2022)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew James Kaser

Introduction

Matthew James Kaser is a notable inventor based in Montvale, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work focuses on developing effective pharmaceutical formulations that address various health concerns.

Latest Patents

Among his latest patents, Kaser has developed a pharmaceutical composition that includes guaifenesin, naproxen, and at least one additional active ingredient selected from antitussives, decongestants, or antihistamines. This innovative formulation aims to provide relief for patients suffering from respiratory issues. Another notable patent involves a formulation for oral administration that combines an expectorant, an analgesic, and an additional active ingredient with modified release properties. This formulation is designed to deliver therapeutic effects for each active ingredient for up to 12 hours.

Career Highlights

Throughout his career, Kaser has worked with reputable companies such as RB Health LLC and Reckitt Benckiser Inc. His experience in these organizations has allowed him to refine his skills and contribute to the development of effective pharmaceutical products.

Collaborations

Kaser has collaborated with talented individuals in the industry, including Raghu Cavatur and Kevin Chen. These partnerships have fostered innovation and enhanced the quality of his work.

Conclusion

Matthew James Kaser's contributions to pharmaceutical formulations demonstrate his commitment to improving health outcomes through innovation. His patents reflect a deep understanding of the complexities of drug formulation and the needs of patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…